Orbimed Advisors - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,406,691
-40.4%
893,668
-23.5%
0.12%
-29.9%
Q2 2023$9,067,312
+15.7%
1,168,468
-15.0%
0.16%
+6.5%
Q1 2023$7,834,468
-17.3%
1,374,468
-14.5%
0.15%
-14.9%
Q4 2022$9,468,576
+41.7%
1,607,568
-23.0%
0.18%
+46.0%
Q3 2022$6,680,000
-28.6%
2,087,5680.0%0.12%
-26.6%
Q2 2022$9,352,000
-16.1%
2,087,5680.0%0.17%
-6.6%
Q1 2022$11,148,000
-67.6%
2,087,568
-10.7%
0.18%
-59.0%
Q4 2021$34,362,000
-29.7%
2,337,5740.0%0.44%
-17.7%
Q3 2021$48,879,000
+18.2%
2,337,5740.0%0.54%
+28.5%
Q2 2021$41,352,000
-27.8%
2,337,5740.0%0.42%
-21.9%
Q1 2021$57,271,000
-42.1%
2,337,574
-20.0%
0.54%
-38.2%
Q4 2020$98,909,000
+35.3%
2,921,9670.0%0.86%
-5.9%
Q3 2020$73,078,000
-25.9%
2,921,9670.0%0.92%
-33.8%
Q2 2020$98,558,0002,921,9671.39%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Column Group LLC 4,768,181$84,349,00011.94%
Memorial Sloan Kettering Cancer Center 602,272$10,654,0006.96%
Euclidean Capital LLC 996,734$17,632,0005.72%
Invus Financial Advisors, LLC 1,007,575$17,824,0003.55%
EcoR1 Capital, LLC 3,092,218$54,701,0002.04%
Orbimed Advisors 2,337,574$41,352,0000.42%
EMERALD ADVISERS, LLC 602,758$10,663,0000.39%
EMERALD MUTUAL FUND ADVISERS TRUST 557,210$9,857,0000.32%
Casdin Capital, LLC 601,515$10,641,0000.27%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 53,000$938,0000.25%
View complete list of ORIC PHARMACEUTICALS INC shareholders